CD274 and triple-negative breast carcinoma: In Wong et al.’s publication, the PD-L1+ triple-negative breast cancer MDA-MB-231 cell line was targeted by the immunotoxin Anti-PD-L1-Saporin via PCI and resulted in an in vitro proof-of-concept of PCI-enhanced targeting and elimination of PD-L1-positive immunosuppressive cells.